Rare stability in dogs with myxomatous mitral valve disease: Clinical observations of loop diuretic withdrawal after congestive heart failure
Tung Hsueh, I-Ping Chan, Chung-Chun Yang, Shiun-Long Lin · 2026
Read Rare stability in dogs with myxomatous mitral valve disease: Clinical observations of loop diuretic withdrawal after congestive heart failure by Tung Hsueh, I-Ping Chan, Chung-Chun Yang, Shiun-Long Lin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13313972.txt.
Description
Tung Hsueh and colleagues describe, in a 2026 study, a group of dogs whose heart failure stabilized so completely that water pills could be stopped. Myxomatous mitral valve disease is the usual route to heart failure in dogs, and diuretics are lifelong once failure appears. Searching 3,055 records from a Taiwanese veterinary hospital spanning 2012 to 2022, the team looked for dogs stable without diuretics for a year after a failure diagnosis.
Only six dogs qualified: five Maltese and one toy poodle, aged a median 8.5 years. They had needed treatment for a median of 675 days before tapering, then stayed stable in follow-ups past four years in the longest case. Kidney strain on blood tests, a shrinking heart shape on X-ray, and long calm periods marked the candidates. Three dogs stopped all cardiac medicines. The authors suggest factors sometimes drive a failure episode, and monitored tapering can improve life quality for chosen dogs.
Catalog record
| CREATOR | Tung Hsueh, I-Ping Chan, Chung-Chun Yang, Shiun-Long Lin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |